OncoCyte Corporation

APERIGEN

Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents for medical use;Diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for scientific or research use; reagents for scientific or medical research use;The wording APERIGEN has no meaning in a foreign language.;Providing cancer screening services;Liquid and tissue biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for testing biomarkers; cancer screening tests and devices, namely, medical devices for detecting cancer; blood testing apparatus for cancer diagnosis; medical testing devices for tumor diagnosis;Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto;

DETERMA RX IO TX

The mark consists of the block letter wording DETERMA in blue, stacked over three leaf shape designs being squares having rounded corners at the top left and bottom right of each, and wherein the first is green with the letters Rx appearing in white in the center, the second is blue with the letters IO appearing in white in the center, and the third is red with the letters Tx appearing in white in the center.;The color(s) blue, green, red, and white is/are claimed as a feature of the mark.;Biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for testing biomarkers; Biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; Cancer screening tests and devices, namely, medical devices for detecting risk factors and probability of cancer reoccurrence; Cancer screening tests and devices, namely, medical devices for evaluating immunotherapy cancer treatment options; Cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; Medical testing device for diagnosing cancer and detecting biological traits that effect the risk of reoccurrence; Medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patient; Blood testing apparatus for cancer diagnosis and evaluation of treatment options; Medical testing devices for tumor diagnosis and treatment evaluation;